Most advanced Siemens MR scanners provide highest intraoperative image
quality and best workflow available

MINNEAPOLIS, Feb. 13, 2014 /PRNewswire/ – IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
(“IMRIS” or the “Company”) today announced US Food and Drug
Administration clearance of the newest generation VISIUS Surgical Theatre which integrates Siemens’ latest high-field MR
scanners.

The new core imaging technology based on Siemens Aera 1.5T(tesla) and
Skyra 3.0T technology helps IMRIS deliver better image quality with
higher signal-to-noise ratio, faster 3D image acquisition, and improved
ease-of-use and workflow during neurosurgical procedures using
intraoperative MRI (iMRI).

“These high-field intraoperative scanner options will give a hospital’s
clinical team imaging applications and image quality that increase
productivity,” said IMRIS President and CEO Jay D. Miller. “We are
bringing the latest and unequaled imaging technology into the operating
room where it can make the most difference – during the surgery. IMRIS
systems have been used in over 13,000 cases worldwide to improve
outcomes in brain tumor and epilepsy surgeries in particular.”

The addition of these MR systems expands the industry-leading 1.5T and
3.0T MRI choices hospitals have when considering the unique,
ceiling-mounted IMRIS solution for intraoperative imaging which brings
the MRI to the patient during the procedure.

The first installation of this new generation VISIUS Surgical Theatre
will be a four-room hybrid operating room suite, known as the Center
for Surgical Innovation (CSI) at Dartmouth-Hitchcock Medical Center in
Lebanon, NH. “Surgeons are too often limited by what they cannot see –
anatomy that is difficult to reach or diseases that are not visible to
the naked eye,” says Sohail Mirza MD, medical director of CSI and chair
of orthopedics at Dartmouth–Hitchcock. “The advanced integration of
state-of-the-art imaging tools in CSI will allow surgeons and engineers
to innovate like never before, rapidly developing, testing, and
validating new surgical tools and techniques, with the goal of
achieving better, safer, and, in some cases, less-costly care for
patients everywhere.”

The Dartmouth–Hitchcock installation will also include a VISIUS
intraoperative CT (iCT), which utilizes the technology of the 64-slice
Siemens SOMATOM Definition AS scanner, making it the only operating suite in the world
with both VISIUS iMRI and iCT modalities able to serve multiple
operating rooms (ORs) without moving the patient.

Inside a VISIUS Surgical Theatre equipped with either high-field iMRI or
iCT, surgeons have on-demand access to real-time data and
state-of-the-art imaging, during the procedure from the OR table. The
Company also designs and manufactures proprietary head fixation
devices, imaging coils, and OR tables for use in this unique and
multifunctional intraoperative environment.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre – a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 56 leading medical
institutions around the world.

SOURCE IMRIS Inc.

Image with caption: “The IMRIS VISIUS Surgical Theatre with intraoperative MRI (iMRI) now has integrated into it the latest generation MR scanners based on Siemens technology. (CNW Group/IMRIS Inc.)”. Image available at: http://photos.newswire.ca/images/download/20140213_C4061_PHOTO_EN_36714.jpg